U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992323) titled 'Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol' on April 10.
Brief Summary: The primary aim of this study is to investigate the potential cardioprotective effects of daily nutritional doses of eicosapentaenoic acid (EPA) enriched with hydroxytyrosol (HT) on cardiovascular health, as well as its modulatory impact on the intestinal microbiota. This investigation will be conducted through a randomized, double-blind, crossover, and controlled nutritional intervention trial. The study population will include two cohorts: one with normotriglyceridemic individuals, and another with hypertriglyceridemic individuals....